Compositions of immune cell subtypes within CD45+ leukocytes are different between cholangiocarcinoma subtypes and are different between patients whose OS is longer than 3 years (OS > 3 years) and those whose OS is shorter than 3 years (OS < 3 years) (Fig. 1C–E). This evidence concerns the gene PTPRC and cholangiocarcinoma.